ArticleCase reports in ophthalmology
Utility of High-Dose Steroids in Treatment-Resistant Carotid-Cavernous Fistulas: A Case Report.
Article in Case reports in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Carotid-cavernous fistulas (CCFs) are rare arteriovenous communications between the carotid arterial system and the cavernous sinus that can result in vision-threatening and life-threatening complications. Severe cavernous sinus and orbital venous congestion is managed with prompt endovascular intervention to prevent irreversible cranial nerve and ocular pathology. While high-dose corticosteroids have been reported to improve clinical symptoms in a small number of cases of superior ophthalmic vein thrombosis (SOVT) secondary to CCF, their role in the management of severe orbital venous congestion without radiographically confirmed SOVT remains unclear. Case Presentation: We report the case of a 67-year-old female who developed a direct CCF following a high-speed motor vehicle collision. Two weeks after the event, she presented with progressive diplopia, right-sided ptosis, and headache. Diagnostic transradial cervical and cerebral angiography revealed a high-flow, direct internal right CCF with bilateral superior ophthalmic vein (SOV) and cavernous sinus opacification. Despite multiple transvenous coil embolizations and subsequent flow diverter stent placements, she continued to develop severe, progressive sequelae of orbital venous congestion without evidence of SOVT on imaging. Following initiation of high-dose oral corticosteroids 5 days prior to additional flow diverter stent placement, the patient experienced symptomatic improvement with subsequent recurrence found clinically following steroid taper and cessation. No changes were noted on her angiograms over this period, and her orbital congestion improved after restarting a high-dose corticosteroid pulse. A final curative trans-orbital direct SOV puncture for coiling was performed, resulting in complete symptom resolution. Conclusion: This case demonstrates that systemic corticosteroid therapy may be a valuable adjunctive treatment for CCF-associated, vision-threatening venous congestion refractory to standard endovascular intervention. Early recognition of progressive orbital venous congestion is critical to prevent permanent vision loss. A multimodal approach combining flow diversion, coil embolization, and corticosteroids may help achieve favorable outcomes in complex cases. This case adds to the limited literature supporting corticosteroid use in this challenging clinical scenario and highlights the importance of aggressive ophthalmologic monitoring following CCF diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.